Samir R. Patel - 26 Dec 2024 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
Director
Signature
/s/ Torsten Hombeck, as Attorney-in-Fact
Issuer symbol
AKTX
Transactions as of
26 Dec 2024
Net transactions value
+$1,800
Form type
4
Filing time
30 Dec 2024, 16:30:06 UTC
Previous filing
27 Dec 2024
Next filing
07 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKTX Ordinary Shares, par value $0.0001 per share Award $1,600 +3,200,000 +0.06% $0.000500 5,248,903,500 26 Dec 2024 PranaBio Investments LLC F1, F2
transaction AKTX Ordinary Shares, par value $0.0001 per share Award $200 +400,000 +0.01% $0.000500 5,249,303,500 27 Dec 2024 PranaBio Investments LLC F1, F2, F3
holding AKTX Ordinary Shares, par value $0.0001 per share 91,396,000 26 Dec 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
F2 On December 26, 2024, the Reporting Person acquired 3,200,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share.
F3 On December 27, 2024 the Reporting Person acquired 400,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share.